Home
Newsletter
Events
Blogs
Reports
Graphics
RSS
About Us
Contact Us
Write for Us
Media Info
Advertising Info

Pfizer

Pfizer forced to cut 20 percent of U.S. sales force

Tuesday, January 23, 2007 by: Jessica Fraser
Tags: Pfizer, generic drugs, drug companies


Most Viewed Articles
https://www.naturalnews.com/021482_Pfizer_generic_drugs.html
Delicious
diaspora
Print
Email
Share

(NewsTarget) Pfizer Inc. -- the world's top pharmaceuticals manufacturer -- announced earlier this week that it would cut 20 percent of its U.S. sales workforce as part of its plan to reduce costs and boost earnings in the coming years.

The job cuts will affect 2,200 employees at all levels of the drug giant's sales operation, from field sales representatives to upper-level management, according to Pfizer spokesman Paul Fitzhenry. While the latest workforce reduction is set to end layoffs in the U.S. sales sector, the rest of the company's operations are still under review and could possibly experience cuts, Fitzhenry said.

According to Prudential Equity analyst Tim Anderson, the job cuts should help Pfizer successfully reign in costs.

"The easier way to win is to have a pipeline (of new drugs in development), but until you have more sources of growth ahead of you, cutting costs is the smart thing to do," Anderson told Reuters.

In July 2006, new Pfizer Chief Executive Jeffrey Kindler took over for Hank McKinnell, and in mid-October the company announced it would review its operations in an effort to cut costs. Kindler said Pfizer hopes to save roughly $4 billion per year by 2008.

With 20 percent of its sales force now unemployed, Pfizer said it would still be able to maintain its sales operations with its 11,000 remaining employees. However, Pfizer could announce more cuts to further balance costs, Anderson said.

"I wouldn't be surprised if this was just the first step, but just how low to go is a very tough question to answer," he said. "I actually don't think the industry knows how far they can cut."

Pfizer's profits have suffered recently after slow sales of older medications and failed attempts at launching newer drugs. The company said it likely will not experience revenue growth again until 2009.

###


Receive Our Free Email Newsletter

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.


comments powered by Disqus


Natural News Wire (Sponsored Content)

Science.News
Science News & Studies
Medicine.News
Medicine News and Information
Food.News
Food News & Studies
Health.News
Health News & Studies
Herbs.News
Herbs News & Information
Pollution.News
Pollution News & Studies
Cancer.News
Cancer News & Studies
Climate.News
Climate News & Studies
Survival.News
Survival News & Information
Gear.News
Gear News & Information
Glitch.News
News covering technology, stocks, hackers, and more